Location: New York, NY
CIK: 0001482416 · Show all filings
Period: Q4 2016 (← Previous) (Next →)
Filing Date: Feb 14, 2017
Total Value: $171M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ACAD | ACADIA PHARMACEUTICALS INC | 563,200 | $16.24M | 9.5% | — | — | Put | 004225108 |
| — | QUOTIENT LTD | 2,237,771 | $10.83M | 6.3% | $13.82 | — | SHS | G73268107 |
| SNY | SANOFI SA | 210,000 | $8.492M | 5.0% | $43.75 | — | Put | 80105N105 |
| — | CERNER CORP | 149,200 | $7.068M | 4.1% | — | — | Put | 156782104 |
| — | GLAXOSMITHKLINE PLC | 180,811 | $6.963M | 4.1% | $38.51 | — | SPONSORED ADR | 37733W105 |
| — | GLAXOSMITHKLINE PLC | 170,000 | $6.547M | 3.8% | $38.51 | — | Call | 37733W105 |
| PHG | KONINKLIJKE PHILIPS NV | 209,502 | $6.404M | 3.7% | $28.32 | — | NY REG SH NEW | 500472303 |
| — | HILL-ROM HOLDINGS INC | 106,594 | $5.984M | 3.5% | $52.87 | — | COM | 431475102 |
| — | TABULA RASA HEALTHCARE INC | 388,054 | $5.813M | 3.4% | $14.32 | — | COM | 873379101 |
| EW | EDWARDS LIFESCIENCES CORP | 55,000 | $5.154M | 3.0% | $32.40 | 0.0% | COM | 28176E108 |
| CAH | CARDINAL HEALTH INC | 70,000 | $5.038M | 2.9% | $60.99 | -9.3% | Put | 14149Y108 |
| CAH | CARDINAL HEALTH INC | 68,885 | $4.958M | 2.9% | $60.99 | -9.3% | COM | 14149Y108 |
| LLY | ELI LILLY AND CO | 67,000 | $4.928M | 2.9% | $64.22 | 0.0% | COM | 532457108 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 46,723 | $4.822M | 2.8% | $99.44 | 0.0% | COM | 98956P102 |
| — | WALGREENS BOOTS ALLIANCE INC | 57,000 | $4.717M | 2.8% | — | — | Put | 931427108 |
| AMGN | AMGEN INC | 30,000 | $4.386M | 2.6% | $114.37 | 0.0% | Put | 031162100 |
| ZTS | ZOETIS INC | 80,000 | $4.282M | 2.5% | — | — | Put | 98978V103 |
| — | ALLERGAN PLC | 20,000 | $4.2M | 2.5% | — | — | Put | G0177J108 |
| — | ADVANCED ACCELERATOR APPLICATIONS SA | 153,332 | $4.103M | 2.4% | $28.98 | — | SPONSORED ADS | 00790T100 |
| ACRS | ACLARIS THERAPEUTICS INC | 138,441 | $3.757M | 2.2% | $25.50 | 0.0% | COM | 00461U105 |
| — | ADAMIS PHARMACEUTICALS CORP | 1,051,063 | $3.311M | 1.9% | $4.93 | — | COM NEW | 00547W208 |
| — | NATUS MEDICAL INC | 90,865 | $3.162M | 1.8% | $37.56 | — | COM | 639050103 |
| PHG | KONINKLIJKE PHILIPS NV | 100,000 | $3.057M | 1.8% | $28.32 | — | Call | 500472303 |
| — | RIGEL PHARMACEUTICALS INC | 1,263,390 | $3.007M | 1.8% | $2.14 | — | COM NEW | 766559603 |
| AMGN | AMGEN INC | 20,000 | $2.924M | 1.7% | $114.37 | 0.0% | Call | 031162100 |
| BSX | BOSTON SCIENTIFIC CORP | 120,500 | $2.606M | 1.5% | $21.82 | 0.0% | Call | 101137107 |
| UNH | UNITEDHEALTH GROUP INC | 16,187 | $2.591M | 1.5% | $121.12 | +6.6% | COM | 91324P102 |
| HUM | HUMANA INC | 12,500 | $2.55M | 1.5% | — | — | Put | 444859102 |
| — | AETNA INC | 20,000 | $2.48M | 1.4% | $124.00 | — | COM | 00817Y108 |
| BSX | BOSTON SCIENTIFIC CORP | 113,500 | $2.455M | 1.4% | $21.82 | 0.0% | COM | 101137107 |
| PRGO | PERRIGO COMPANY PLC | 29,329 | $2.441M | 1.4% | $92.15 | -5.9% | SHS | G97822103 |
| — | CHEMOCENTRYX INC | 325,250 | $2.407M | 1.4% | $4.49 | — | COM | 16383L106 |
| AMGN | AMGEN INC | 16,430 | $2.402M | 1.4% | $114.37 | 0.0% | COM | 031162100 |
| SYK | STRYKER CORP | 20,000 | $2.396M | 1.4% | — | — | Put | 863667101 |
| — | IMMUNOMEDICS INC | 506,978 | $1.861M | 1.1% | $3.67 | — | COM | 452907108 |
| — | ACTINIUM PHARMACEUTICALS INC | 1,649,078 | $1.443M | 0.8% | $1.34 | — | COM | 00507W107 |
| — | ADAMAS PHARMACEUTICALS INC | 69,215 | $1.17M | 0.7% | $16.30 | — | COM | 00548A106 |
| SRPT | SAREPTA THERAPEUTICS INC | 35,000 | $960K | 0.6% | — | — | Put | 803607100 |
| — | FLAMEL TECHNOLOGIES SA | 91,413 | $950K | 0.6% | $10.39 | — | SPONSORED ADR | 338488109 |
| — | AEGLEA BIO THERAPEUTICS INC | 188,485 | $820K | 0.5% | $4.87 | — | COM | 00773J103 |
| — | FORWARD PHARMA A/S | 51,246 | $769K | 0.4% | $17.92 | — | SPONSORED ADR | 34986J105 |
| OASMY | OASMIA PHARMACEUTICAL AB | 182,270 | $512K | 0.3% | $3.35 | — | ADR | 67421W109 |
| — | BIOPHARMX CORP | 1,143,400 | $428K | 0.2% | $0.37 | — | COM | 09072X101 |